While glucagon-like peptide-1 (GLP-1) agonists for diabetes and weight loss remain in short supply, some clinicians have turned to compounding pharmacies to fill prescriptions. Yet news reports and ...

In the early days of the Covid pandemic, gravely ill patients began to fill America’s hospitals. Hospitals ran short of essential treatment medications and were unable to source those drugs from ...

If you’ve received medication through popular telemedicine companies like Hims & Hers Health, you’re probably familiar with drug compounding. That’s the process of creating customized medicine for a ...

The FDA says shortages of GLP-1s are over, but many patients are still getting what are essentially copied medications. The market for drugs that treat obesity and help people lose weight is soaring.

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have been associated with at least 100 hospitalizations and 10 deaths, the chief ...